Torthaí cuardaigh - William D. Hastings
- 1 - 7 toradh as 7 á dtaispeáint
-
1
-
2
IL-21 and TGF-β are required for differentiation of human TH17 cells de réir Yang Li, David E. Anderson, Clare Baecher‐Allan, William D. Hastings, Estelle Bettelli, Mohamed Oukka, Vijay K. Kuchroo, David A. Hafler
Foilsithe / Cruthaithe 2008Artigo -
3
TIM‐3 is expressed on activated human CD4<sup>+</sup> T cells and regulates Th1 and Th17 cytokines de réir William D. Hastings, David E. Anderson, Nasim Kassam, Ken Koguchi, Edward Greenfield, Sally C. Kent, Xin Xiao Zheng, Terry B. Strom, David A. Hafler, Vijay K. Kuchroo
Foilsithe / Cruthaithe 2009Artigo -
4
TGF-β Induces IL-9 Production from Human Th17 Cells de réir Gaëlle Bériou, Elizabeth M. Bradshaw, Ester Lozano, Cristina M. Costantino, William D. Hastings, Tihamer Orban, Wassim Elyaman, Samia J. Khoury, Vijay K. Kuchroo, Clare Baecher‐Allan, David A. Hafler
Foilsithe / Cruthaithe 2010Artigo -
5
Combinations with Allosteric SHP2 Inhibitor TNO155 to Block Receptor Tyrosine Kinase Signaling de réir Chen Liu, Hengyu Lu, Hongyun Wang, Alice Loo, Xiamei Zhang, Guizhi Yang, Colleen Kowal, Scott Delach, Ye Wang, Silvia Goldoni, William D. Hastings, Karrie Wong, Hui Gao, Matthew J. Meyer, Susan E. Moody, Matthew J. LaMarche, Jeffrey A. Engelman, Juliet Williams, Peter S. Hammerman, Tinya J. Abrams, Morvarid Mohseni, Giordano Caponigro, Huai‐Xiang Hao
Foilsithe / Cruthaithe 2020Artigo -
6
Dynamic single-cell RNA sequencing identifies immunotherapy persister cells following PD-1 blockade de réir Kartik Sehgal, Andrew Portell, Elena Ivanova, Patrick H. Lizotte, Navin R. Mahadevan, Jonathan Greene, Amir Vajdi, Carino Gurjao, Tyler J. Teceno, Luke J. Taus, Tran C. Thai, Shunsuke Kitajima, Derek Liu, Tetsuo Tani, Moataz Noureddine, Christie J. Lau, Paul T. Kirschmeier, David Liu, Marios Giannakis, Russell W. Jenkins, Prafulla C. Gokhale, Silvia Goldoni, Maria Pinzon-Ortiz, William D. Hastings, Peter S. Hammerman, Juan J. Miret, Cloud P. Paweletz, David A. Barbie
Foilsithe / Cruthaithe 2020Artigo -
7
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms de réir Ye Wang, Morvarid Mohseni, Angelo L. Grauel, Javier Estrada, Wei Guan, Simon Liang, Jiyoung Choi, Minying Pu, Dongshu Chen, Tyler Laszewski, Stephanie Schwartz, Jane Gu, Leandra Mansur, Tyler Burks, Lauren K. Brodeur, Roberto Velazquez, Steve G. Kovats, Bhavesh Pant, Giri Buruzula, Emily Deng, Julie Chen, Farid Sari‐Sarraf, Christina Dornelas, Malini Varadarajan, Haiyan Yu, Chen Liu, Joanne Lim, Huai-Xiang Hao, Xiaomo Jiang, Anthony S. Malamas, Matthew J. LaMarche, Felipe C. Geyer, Margaret E. McLaughlin, Carlotta Costa, Joel P. Wagner, David A. Ruddy, Pushpa Jayaraman, Nathaniel D. Kirkpatrick, Pu Zhang, Oleg Iartchouk, Kimberly Aardalen, Viviana Cremasco, Glenn Dranoff, Jeffrey A. Engelman, Serena J. Silver, Hongyun Wang, William D. Hastings, Silvia Goldoni
Foilsithe / Cruthaithe 2021Artigo
Uirlisí cuardaigh:
Ábhair a bhaineann le hábhar
Biology
Immunology
Cell biology
Immune system
T cell
Genetics
Biochemistry
Cancer research
Cancer
Cancer immunotherapy
Endocrinology
Gene
IL-2 receptor
Immunotherapy
Interleukin 17
Interleukin 21
Molecular biology
Receptor
Secretion
Allosteric regulation
Antibody
Antigen
Antigen-presenting cell
B cell
B-1 cell
Biotechnology
Block (permutation group theory)
Blockade
CD28
Cell